---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273828880.md"
description: "With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's \"Special Regulations on the Registration of Traditional Chinese Medicine\" is entering its final window period. This regulation, referred to in the industry as the \"death clause\" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibited"
datetime: "2026-01-27T10:41:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273828880.md)
  - [en](https://longbridge.com/en/news/273828880.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273828880.md)
---

# 

Adverse Reactions

### Related Stocks

- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [600436.CN](https://longbridge.com/en/quote/600436.CN.md)
- [000999.CN](https://longbridge.com/en/quote/000999.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [00570.HK](https://longbridge.com/en/quote/00570.HK.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [600129.CN](https://longbridge.com/en/quote/600129.CN.md)
- [600535.CN](https://longbridge.com/en/quote/600535.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [600085.CN](https://longbridge.com/en/quote/600085.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [600329.CN](https://longbridge.com/en/quote/600329.CN.md)
- [513200.CN](https://longbridge.com/en/quote/513200.CN.md)
- [00874.HK](https://longbridge.com/en/quote/00874.HK.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [002603.CN](https://longbridge.com/en/quote/002603.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [000538.CN](https://longbridge.com/en/quote/000538.CN.md)
- [600566.CN](https://longbridge.com/en/quote/600566.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [01666.HK](https://longbridge.com/en/quote/01666.HK.md)
- [03613.HK](https://longbridge.com/en/quote/03613.HK.md)
- [600332.CN](https://longbridge.com/en/quote/600332.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)

## Related News & Research

- [Baiyunshan Pharma Gets Approval for Carbocisteine Oral Solution's Registration in Macau](https://longbridge.com/en/news/281478355.md)
- [Baiyunshan Pharmaceutical Gets Nod for Marketing Transfer of Bone Health Drug](https://longbridge.com/en/news/281477935.md)
- [Sino Biopharmaceutical Unit Enrolls First Patient in Gastric Cancer Drug Trial](https://longbridge.com/en/news/282827241.md)
- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)
- [Fosun Pharma Unit Gets China Nod for Amyloidosis Drug Trial](https://longbridge.com/en/news/282675084.md)